Your $3,000: A Blissful Journey into the World of Dividend-Paying Stocks Congratulations! You’ve reached a financial milestone. After diligently paying off your high-interest debt and fortifying your emergency savings, you’ve got some extra cash on hand. And what’s more, you’re not in a rush to spend it. So, what’s a savvy investor to do? Why,…
Insights into Nvidia’s Upcoming Fourth-Quarter Earnings Report: What Investors Should Watch Out For As the technology sector continues to evolve at an unprecedented pace, one name that consistently stands out is Nvidia Corporation (NVDA). Known for its innovative graphics processing units (GPUs) and system on chips (SoCs), Nvidia has been a game-changer in the fields…
Dermata Therapeutics, Inc. Highlights Recent Corporate Progress Dermata Nears Completion of Enrollment in DMT310 Phase 3 Clinical Trial Dermata Therapeutics, Inc. is making strides in its DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial. The company is approaching completion of enrollment, bringing them one step closer to potentially revolutionizing acne treatment. Dermata…
A New Leader Rises: Jason Edelmann Takes the Helm at Bank of America Fort Lauderdale FORT LAUDERDALE, Fla., March 20, 2025 In an exciting development for the banking industry, Bank of America has announced that Jason Edelmann will be taking on the role of president at Bank of America Fort Lauderdale. This appointment comes as…
AUDUSD tests support area near 200-day SMA AUDUSD has been on a downward slide again, marking its fourth consecutive week in the red. It recently dipped to a two-month low of 0.6612 but held above the 200-day simple moving average (SMA) and the constraining falling line from February 2023, which increases speculation as to whether…
Q4 Reporting Period: A Look at Netflix, Palantir, and Royal Caribbean Strong Results Across the Board Throughout the Q4 reporting period, three companies, Netflix, Palantir, and Royal Caribbean, all posted notably strong results. This came as a pleasant surprise to many investors and analysts, who were cautiously optimistic about the performance of these companies given…
Phathom Pharmaceuticals (PHAT) Surprises with Better-than-Expected Quarterly Loss Phathom Pharmaceuticals, Inc. (PHAT) recently reported its fourth quarter and full-year 2021 financial results, revealing a smaller quarterly loss than anticipated by analysts. The company reported a loss of $0.79 per share for the quarter, which was $0.19 better than the Zacks Consensus Estimate of a loss…
Medallion Bank’s Shift to Three-Month CME Term SOFR for Preferred Stock Dividends: Medallion Bank, a Nasdaq-listed financial institution with the ticker symbol “MBNKP,” made an important announcement on March 28, 2025. Starting April 1, 2025, the benchmark rate used to determine the dividend rate for each period during the floating rate period of the Bank’s…
